TrialRespiratory research2020

DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.

Andrew Menzies-Gow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.